Advertisement
Organisation › Details
Molecure S.A. (WSE: MOC)
Start | 2022-03-28 renamed | |
Group | Molecure (Group) | |
Predecessor | OncoArendi Therapeutics S.A. (WSE: OAT) | |
Industry | BIOTECH | |
Region | Warszawa (Warsaw) | |
Country | Poland | |
Street | 101 ul. Zwirki i Wigury | |
City | 02089 Warszawa | |
Tel | +48-22-552-6724 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | PLN | |
Annual sales | 1,640,000 (income, operating, consolidated (2022) 2022-12-31) | |
Profit | -15,260,000 (2022-12-31) | |
Cash | 66,000,000 (2022-12-31) | |
Record changed: 2023-08-02 |
Advertisement
More documents for Molecure (Group)
- [1] Molecure S.A.. (7/21/23). "Press Release: Molecure Completes Successful Secondary Public Offering (SPO) of approximately PLN 50 Million (USD 12 Million)". Warsaw....
- [2] Molecure S.A.. (3/30/23). "Press Release: Molecure Announces Full Year Financial 2022 Results – a Year of Significant Progress". Warsaw....
- [3] Galapagos N.V.. (11/5/20). "Press Release: OncoArendi and Galapagos Enter into Exclusive Collaboration on Chitinase Inhibitors in Fibrosis". Mechelen & Warsaw....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top